The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Description of ALK+ NSCLC patient characteristics and ALK testing patterns.
Heather A. Wakelee
Consultant or Advisory Role - Novartis (U)
Research Funding - Novartis; Pfizer; Roche/Genentech; Xcovery
Medha Sasane
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Jie Zhang
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Alexander R. Macalalad
Consultant or Advisory Role - Novartis
Research Funding - Novartis
Philip J Galebach
Consultant or Advisory Role - Novartis
Research Funding - Novartis
John Jarvis
Consultant or Advisory Role - Novartis
Research Funding - Novartis
Andrew James Kageleiry
Consultant or Advisory Role - Novartis
Research Funding - Novartis
Qing Huang
Consultant or Advisory Role - Novartis
Research Funding - Novartis
Kenneth W. Culver
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Eric Qiong Wu
Consultant or Advisory Role - Novartis
Research Funding - Novartis
Annie Guérin
Consultant or Advisory Role - Novartis
Research Funding - Novartis